Assenagon Asset Management S.A. Bolt Biotherapeutics, Inc. Transaction History

Assenagon Asset Management S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$1.27 - $1.95 $85,759 - $131,677	-67,527 Reduced 29.9%	158,289 $202,000
Q4 2022 Jan 12, 2023	SELL	$1.26 - $1.48 $68,247 - $80,164	-54,165 Reduced 19.35%	225,816 $294,000
Q3 2022 Oct 27, 2022	BUY	$1.72 - $2.61 $7,617 - $11,559	4,429 Added 1.61%	279,981 $414,000
Q2 2022 Jul 27, 2022	BUY	$1.41 - $2.91 $388,528 - $801,856	275,552 New	275,552 $562,000

24.3M

Ticker BOLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,641,500
Market Cap $28.2M
Description
Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

Stay updated on Assenagon Asset Management S.A. with notifications on news.